Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
CA 2324510 A1 · Owner: The Regents Of The University Of California · Inventors: Freimer, Nelson B.; Chen, Hong
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to the mammalian PACAP gene. The invention relates to methods for the identification of compounds that modulates the expression of PACAP and to using such compounds as therapeutics agents in the treatment of PACAP disorders. The invention also relates to methods for the diagnostic evaluation, genetic testing and prognosis of PACAP mediated disorders, and to methods and compositions for the treatment of these disorders. The invention also relates to use of the PACAP gene and/or gene products as markers for fine structure mapping of a region of human chromosome 18, including a region of the chromosome involved in mediating neuropsychiatric disorders.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 2, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 2, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 2, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.